ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0509

Functional Anti-M3R Autoantibodies in Sjögren’s Disease: From Gland to Circulation

Martha Tsaliki1, Joshua Cavett2, Biji T Kurien3, valerie Lewis3, John Ice4, Devavrat Dave5, Sina Khosravani5, Menerva Racy5, Rebecca Wood6, Seunghee Cha7, A. Darise Farris3, Kristi A. Koelsch5 and R. Scofield3, 1The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Oklahoma Medicar Research Foundtion, Oklahoma City, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4OKC Veterans Affairs Medical Center, Oklahoma City, OK, 5Oklahoma Medical Research Foundation, oklahoma City, 6University of Oklahoma Health Sciences Center, Edmond, OK, 7University of Florida, Gainesville

Meeting: ACR Convergence 2025

Keywords: Autoantibody(ies), autoimmune diseases, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0506–0521) Sjögren’s Disease – Basic & Clinical Science Poster I: Etiology, Pathogenesis, Diagnosis

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s disease (SjD) is a systemic autoimmune disease characterized by immune-mediated damage to salivary and lacrimal glands. While autoantibodies against muscarinic type 3 receptor (M3R) have long been implicated in disease pathogenesis, their clinical relevance remains unclear. We hypothesized that pathogenic anti-M3R antibodies originate in inflamed salivary glands and are detectable in both circulation and saliva, where their presence correlates with objective measures of disease activity.

Methods: Recombinant monoclonal antibodies (mAbs) were generated from single cells infiltrating labial salivary glands of classified SjD, NSS (non-Sjögren’s sicca), and overlap SjD subjects and screened for binding to linear and conformational M3R epitopes. Monoclonal antibodies along with matched plasma and saliva samples, as well as an expanded plasma cohort, were screened using a conformational On-Cell Western assay. Functional effects were assessed via inhibition of M3R signaling in a cell-based activity assay. Associations with clinical features and disease activity were evaluated.

Results: A subset of IgG⁺ mAbs from SjD glands bound conformational M3R and inhibited signaling. These features were reflected in matched plasma and, to a lesser extent, saliva. In the larger cohort, plasma anti-M3R reactivity was significantly elevated in SjD and showed association with ocular staining scores, focus scores, and higher ESSDAI biological domain activity. ROC analysis supported moderate diagnostic potential (AUC = 0.736).

Conclusion: These findings demonstrate that anti-M3R antibodies are functionally relevant and detectable in both salivary gland tissue and the circulation. Their association with key glandular and systemic disease features underscores the importance of conformational assays in identifying clinically meaningful autoantibodies. These results suggest that anti-M3R reactivity may define distinct immunopathologic subtype within SjD and serve as a potential biomarker of disease activity.


Disclosures: M. Tsaliki: None; J. Cavett: None; B. Kurien: None; v. Lewis: None; J. Ice: None; D. Dave: None; S. Khosravani: None; M. Racy: None; R. Wood: None; S. Cha: None; A. Farris: Johnson & Johnson Innovative Medicine, 5; K. Koelsch: None; R. Scofield: IQVIA, 1, Jensen Pharmaceuticals, 1.

To cite this abstract in AMA style:

Tsaliki M, Cavett J, Kurien B, Lewis v, Ice J, Dave D, Khosravani S, Racy M, Wood R, Cha S, Farris A, Koelsch K, Scofield R. Functional Anti-M3R Autoantibodies in Sjögren’s Disease: From Gland to Circulation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/functional-anti-m3r-autoantibodies-in-sjogrens-disease-from-gland-to-circulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-anti-m3r-autoantibodies-in-sjogrens-disease-from-gland-to-circulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology